25th week of 2018 patent applcation highlights part 11 |
Patent application number | Title | Published |
20180169098 | SMALL MOLECULES TARGETING HIV-1 NEF | 2018-06-21 |
20180169099 | HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS | 2018-06-21 |
20180169100 | Cancer Stem Cell Targeting Compounds | 2018-06-21 |
20180169101 | METHODS FOR TREATING CANCER | 2018-06-21 |
20180169102 | Composition for Inducing Differentiation and Protection of Neural Stem Cells and Method for Inducing Neuro-Regeneration Using the Same Composition | 2018-06-21 |
20180169103 | METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS | 2018-06-21 |
20180169104 | FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS | 2018-06-21 |
20180169105 | TRIAZINE DERIVATIVES AS INTERFERON-GAMMA INHIBITORS | 2018-06-21 |
20180169106 | CEFTOLOZANE-TAZOBACTAM PHARMACEUTICAL COMPOSITIONS | 2018-06-21 |
20180169107 | METHODS FOR TREATING HYPERSOMNIA | 2018-06-21 |
20180169108 | Drug Combinations For the Treatment of HIV | 2018-06-21 |
20180169109 | TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES | 2018-06-21 |
20180169110 | Nrf2 REGULATORS | 2018-06-21 |
20180169111 | METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT | 2018-06-21 |
20180169112 | PHARMACEUTICAL USE | 2018-06-21 |
20180169113 | HIGH CONCENTRATION FORMULATION | 2018-06-21 |
20180169114 | METHODS FOR REDUCING CELLULAR PROLIFERATION AND TREATING CERTAIN DISEASES | 2018-06-21 |
20180169115 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION | 2018-06-21 |
20180169116 | TREATMENT OF OTITIS MEDIA WITH RETROAURICULAR INJECTION OF AN ANTI-INFLAMMATORY DRUG | 2018-06-21 |
20180169117 | PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUTED PHENYL - (1,3-DIHYDRO-ISOINDOL-2-YL) - METHANONE | 2018-06-21 |
20180169118 | NOVEL PRODRUG SALTS | 2018-06-21 |
20180169119 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN | 2018-06-21 |
20180169120 | COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER | 2018-06-21 |
20180169121 | NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF | 2018-06-21 |
20180169122 | SYNTHETIC COMPOSITION AND METHOD FOR TREATING IRRITABLE BOWEL SYNDROME | 2018-06-21 |
20180169123 | COMBINATION THERAPY WITH A FLAVAGLINE AND 2-DEOXYGLUCOSE | 2018-06-21 |
20180169124 | SUSTAINED RELEASE OF ANTIINFECTIVES | 2018-06-21 |
20180169125 | COMPOSITIONS OF MULTICATIONIC DRUGS FOR REDUCING INTERACTIONS WITH POLYANIONIC BIOMOLECULES AND METHODS OF USE THEREOF | 2018-06-21 |
20180169126 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2018-06-21 |
20180169127 | COMPOSITIONS AND METHODS THAT MODULATE WHITE BLOOD CELLS OR NEUTROPHILS IN A COMPANION ANIMAL | 2018-06-21 |
20180169128 | IMMUNOASSAY OF S-ADENOSYLMETHIONINE USING ANALOGS THEREOF AND PERSONALIZED THERAPEUTICS | 2018-06-21 |
20180169129 | POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF | 2018-06-21 |
20180169130 | COMBINED THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY | 2018-06-21 |
20180169131 | ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN | 2018-06-21 |
20180169132 | COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 2018-06-21 |
20180169133 | Pet Food Compositions | 2018-06-21 |
20180169134 | CHITOSAN MATERIALS FROM CARBONIC ACID SOLUTION | 2018-06-21 |
20180169135 | METHOD FOR PREVENTING TRANSPLANT FAILURE IN A HOST | 2018-06-21 |
20180169136 | USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR PROMOTING CHONDROCYTE GENERATION | 2018-06-21 |
20180169137 | COMPOSITIONS AND METHODS COMPRISING GROWTH FACTORS, CHONDROITIN AND GLUCOSAMINE FOR DEGENERATIVE DISC REGENERATION | 2018-06-21 |
20180169138 | Use Of Gastrointestinally Administered Porous Enteron Sorbent Polymers To Prevent Or Treat Radiation Induced Mucositis, Esophagitis, Enteritis, Colitis, And Gastrointestinal Acute Radiation Syndrome | 2018-06-21 |
20180169139 | COMPOSITION AND METHODS FOR TREATMENT OF LOSS OF FLUIDS LEADING TO HYPOTENSION AND/OR HYPOVOLEMIA | 2018-06-21 |
20180169140 | ANTIBIOTIC COMPOSITIONS AND METHODS OF USE | 2018-06-21 |
20180169141 | INJECTABLE HYDROGELS THAT PROMOTE MINERALIZATION AND AFFORD SUSTAINED RELEASE OF BIOACTIVE IONS | 2018-06-21 |
20180169142 | METHODS, MEANS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF SURGICAL INTERVENTIONS AND INFLAMMATORY SEQUEL | 2018-06-21 |
20180169143 | ZEOLITE MOLECULAR SIEVES FOR THE REMOVAL OF TOXINS | 2018-06-21 |
20180169144 | Citrate Containing Beverage | 2018-06-21 |
20180169145 | COMPOSITIONS AND METHODS FOR USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES | 2018-06-21 |
20180169146 | COMPOSITIONS AND METHODS FOR TRANSIENT GENE THERAPY WITH ENHANCED STABILITY | 2018-06-21 |
20180169147 | METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA + T CELLS | 2018-06-21 |
20180169148 | POINT-OF-CARE AND/OR PORTABLE PLATFORM FOR GENE THERAPY | 2018-06-21 |
20180169149 | OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH | 2018-06-21 |
20180169150 | OPTIMIZED METHODS FOR GENERATION OF CARDIAC STEM CELLS FROM CARDIAC TISSUE AND THEIR USE IN CARDIAC THERAPY | 2018-06-21 |
20180169151 | Pharmaceutical Compositions and Topical Use Thereof | 2018-06-21 |
20180169152 | CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION | 2018-06-21 |
20180169153 | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSES HOST DISEASE | 2018-06-21 |
20180169154 | BACTERIA ENGINEERED TO TREAT A DISEASE OR DISORDER | 2018-06-21 |
20180169155 | COMPOSITIONS AND METHODS FOR SMALL CANINES | 2018-06-21 |
20180169156 | Oral Cancer Vaccine | 2018-06-21 |
20180169157 | TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | 2018-06-21 |
20180169158 | Treatment for Gastroesophageal Reflux Disease Caused by a Neurological Disorder | 2018-06-21 |
20180169159 | CANCER TREATMENT AND DIAGNOSIS | 2018-06-21 |
20180169160 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOUNDS, DISORDERS, AND DISEASES OF THE SKIN | 2018-06-21 |
20180169161 | EUGLENA DERIVED COMPOSITION HAVING IMMUNE RESPONSE INDUCING COMPONENTS | 2018-06-21 |
20180169162 | Method of Producing Cannabidiol Derived Products | 2018-06-21 |
20180169163 | METHODS FOR TREATING NEUROLOGICAL DISORDERS USING NUTRIENT COMPOSITIONS | 2018-06-21 |
20180169164 | METHOD FOR REGULATING EXPRESSIONS OF NOS3 GENE, PLAT GENE, F3 GENE AND/OR SERPINE1 GENE BY USING CHENOPODIUM FORMOSANUM EXTRACT | 2018-06-21 |
20180169165 | JATROPHA CURCAS PROCESSING METHOD AND PRODUCTS | 2018-06-21 |
20180169166 | COMPOSITION FOR INHIBITING AND PREVENTING MYOPATHY, CONTAINING BEAN LEAF EXTRACT AS ACTIVE INGREDIENT | 2018-06-21 |
20180169167 | Lentil Consumption Reduces Artery Remodeling and Restores Arterial Compliance | 2018-06-21 |
20180169168 | ANTICANCER COMPOSITION CONTAINING MIXED HERBAL MEDICINE EXTRACT AS ACTIVE INGREDIENT | 2018-06-21 |
20180169169 | HERBAL COMPOSITION FOR TREATMENT OF BACK PAIN | 2018-06-21 |
20180169170 | OLIVE LEAF EXTRACT AND METHOD OF PRODUCING THE SAME | 2018-06-21 |
20180169171 | PLANT EXTRACTS FOR THE TREATMENT AND PREVENTION OF INFECTIONS | 2018-06-21 |
20180169172 | COMPOUND AND METHOD FOR REDUCING APPETITE, FATIGUE AND PAIN | 2018-06-21 |
20180169173 | Pet Food Compositions | 2018-06-21 |
20180169174 | NOVEL BOTANICAL FORMULATION FOR TREATING SICKLE CELL DISEASE | 2018-06-21 |
20180169175 | FORMULATIONS FOR THE TREATMENT OF DISORDERS OF THE MOUTH, THROAT AND RESPIRATORY TRACT | 2018-06-21 |
20180169176 | NATURAL DRUGS FOR THE TREATMENT OF INFLAMMATION AND MELANOMA | 2018-06-21 |
20180169177 | POLYPEPTIDE SPECIFICALLY BINDING TO CD34 MOLECULE AND USE THEREOF | 2018-06-21 |
20180169178 | AUGMENTING THE IMMUNE RESPONSE BY PROMOTING CELL DEATH OF IMMUNE CELLS | 2018-06-21 |
20180169179 | COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY | 2018-06-21 |
20180169180 | MICAFUNGIN COMPOSITIONS | 2018-06-21 |
20180169181 | FGF RECEPTOR LIGANDS FOR TREATING DIABETES AND OBESITY | 2018-06-21 |
20180169182 | NOVEL RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH INCREASED DURATION OF EFFECT | 2018-06-21 |
20180169183 | DUAL SIGNALING PROTEIN (DSP) FUSION PROTEINS, AND METHODS OF USING THEREOF FOR TREATING DISEASES | 2018-06-21 |
20180169184 | Inhibitor of IGFBP3/TMEM219 Axis and Diabetes | 2018-06-21 |
20180169185 | SYNDECAN PEPTIDES AND POLYPEPTIDES AS INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 (VEGFR2) AND VERY LATE ANTIGEN-4 (VLA-4) | 2018-06-21 |
20180169186 | BETA-CASEIN A2 AND ANTIOXIDANT CAPACITY | 2018-06-21 |
20180169187 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALNUTRITION | 2018-06-21 |
20180169188 | TREATMENT OF X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA WITH A FUSION EDA1 PROTEIN | 2018-06-21 |
20180169189 | CHIMERIC PROTEIN | 2018-06-21 |
20180169190 | INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS | 2018-06-21 |
20180169191 | ADRENOCORTICOTROPIC HORMONE-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR FABRICATING AND USING THEREOF | 2018-06-21 |
20180169192 | Compositions and Methods for Modulating Coagulation | 2018-06-21 |
20180169193 | METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION | 2018-06-21 |
20180169194 | METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION | 2018-06-21 |
20180169195 | METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION | 2018-06-21 |
20180169196 | PURIFICATION AND ISOLATION OF RECOMBINANT OXALATE DEGRADING ENZYMES AND SPRAY-DRIED PARTICLES CONTAINING OXALATE DEGRADING ENZYMES | 2018-06-21 |
20180169197 | AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE | 2018-06-21 |